DoW Breast Cancer, Transformative Breast Cancer Consortium Development Award
This award funds the formation of research teams and preliminary studies involving both scientists and breast cancer advocates to prepare for a future, larger breast cancer consortium grant.
Funder: Dept. of the Army -- USAMRAA
Due Dates: June 24, 2026 (Pre-Application/LOI) | July 8, 2026 (Full Application) | July 13, 2026 (End of Application Verification)
Funding Amounts: Up to $140,000 total costs for a one-year period; one award anticipated.
Summary: Supports development of a multi-institutional breast cancer research consortium and preliminary research to prepare for a future full consortium application.
Key Information: Breast cancer consumer advocates must be active participants; clinical trials are not allowed.
Description
This award supports the formation of a collaborative consortium focused on breast cancer research, providing resources to establish the consortium framework and conduct preliminary research. The intent is to position the team for a competitive application to a future, full Transformative Breast Cancer Consortium Award. The program emphasizes addressing at least one of the Breast Cancer Research Program’s (BCRP) overarching challenges, with a strong requirement for active involvement of breast cancer consumer advocates in both planning and execution. Clinical trials are not permitted under this mechanism.
